Subject:  EMF treatment for MS??......
Date:     Thu, 12 Nov 1998 061629 -0600 (CST)
From:     "Roy L. Beavers" <rbeavers@llion.org>
To:       emfguru <rbeavers@llion.org>
--------------------------------------------------


......An interesting item from Brazil concerning EMF as an MS
(multiple sclerosis) treatment.......guru......

---------- Forwarded message ----------
Date: Wed, 11 Nov 1998 21:11:58 -0800
From: "Celso A. Tavares" 
To: rbeavers 
Subject: help and some advice about

Treatment with electromagnetic field alters the clinical course of
chronic
progressive multiple sclerosis--a case report.

Sandyk R

NeuroCommunication Research Laboratories, Danbury, CT 06811, USA. 

It is estimated that 10-20% of patients with multiple sclerosis (MS)
have a chronic progressive (CP) course characterized by an insidious of
neurological deficits followed by steady progression of disability in
the absence of symptomatic remission. No therapeutic modality has shown
specific efficacy in the treatment of patients with CP MS and there are
no data to indicate that any pharmacologic or other modality alters the
clinical course of CP MS. Treatment with picotesla electromagnetic
fields (EMFs) is a highly effective modality for the symptomatic
management of MS including the chronic progressive form. In addition,
this treatment also appears to alter the natural course of the disease
in CP patients. A 36 year-old man experienced, at the age of 31,
insidious weakness in the legs and several months later developed
difficulties with balance with ataxia of gait.

His gait abnormality progressed slowly over the following years and at
the age of 35 he was severely disabled with spastic paraparesis and
ataxia using a rolling walker for ambulation and a scooter for longer
distances. In particular, his disability had progressed rapidly over the
six months preceding the initiation of treatment with EMFs. He as
classified have CP MS and his prognosis was considered extremely
unfavorable due to the degree of cerebellar and pyramidal tract
involvement and the rapid course of deterioration. In July 1995 the
patient began experimental treatment with EMFs. While receiving three
treatment sessions a week over 12 months he experienced improvement in
cerebellar functions such as gait, balance and tremor as well as bowel
and bladder functions, mood, sleep and cognitive function and resolution
of diplopia, blurring of vision, dysarthria, paresthesias in the hands,
and fatigue. Most remarkably, there was no further progression of the
disease during the course of magnetic therapy. This case illustrated
that treatment with EMFs, in addition to producing symptomatic
improvement, also reverses the clinical course of CP MS.






Archive provided courtesy of WaveGuide, http://www.wave-guide.org
Reprinted with permission of Roy Beavers, http://www.feb.se/EMF-L/EMF-L.html